Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Pavmed Inc Series Z WT (PAVMZ)

Pavmed Inc Series Z WT (PAVMZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
PAVmed and Lucid Diagnostics Provide Strategic Business Update Business Wire - Tue Jan 17, 2023

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors, and its majority-owned...

PAVM : 1.7200 (+4.24%)
PAVMZ : 0.0203 (-55.87%)
LUCD : 0.9007 (-3.15%)
PAVmed and Lucid Diagnostics to Provide Strategic Business Update Business Wire - Wed Jan 11, 2023

PAVmed Inc. (Nasdaq: PAVM, PAVMZ), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors, and its majority-owned subsidiaries...

PAVM : 1.7200 (+4.24%)
PAVMZ : 0.0203 (-55.87%)
LUCD : 0.9007 (-3.15%)
PAVmed Partners with Novosound on Ultrasound Imaging Technology Business Wire - Thu Dec 22, 2022

PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (“PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced...

PAVM : 1.7200 (+4.24%)
PAVMZ : 0.0203 (-55.87%)
LUCD : 0.9007 (-3.15%)
PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform Business Wire - Thu Dec 15, 2022

PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (“PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced...

PAVM : 1.7200 (+4.24%)
PAVMZ : 0.0203 (-55.87%)
LUCD : 0.9007 (-3.15%)
Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry Business Wire - Thu Dec 8, 2022

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq:...

PAVMZ : 0.0203 (-55.87%)
LUCD : 0.9007 (-3.15%)
PAVM : 1.7200 (+4.24%)
Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research Business Wire - Thu Dec 1, 2022

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”),...

PAVMZ : 0.0203 (-55.87%)
LUCD : 0.9007 (-3.15%)
PAVM : 1.7200 (+4.24%)
Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results Business Wire - Mon Nov 14, 2022

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM,...

PAVMZ : 0.0203 (-55.87%)
LUCD : 0.9007 (-3.15%)
PAVM : 1.7200 (+4.24%)
PAVmed to Participate in BTIG Digital Health Forum Business Wire - Fri Nov 11, 2022

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”, the “Company”), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors,...

PAVM : 1.7200 (+4.24%)
PAVMZ : 0.0203 (-55.87%)
LUCD : 0.9007 (-3.15%)
Lucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum Business Wire - Thu Nov 10, 2022

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”, the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM,...

PAVMZ : 0.0203 (-55.87%)
LUCD : 0.9007 (-3.15%)
PAVM : 1.7200 (+4.24%)
Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer Business Wire - Wed Nov 9, 2022

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”, the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM,...

PAVMZ : 0.0203 (-55.87%)
LUCD : 0.9007 (-3.15%)
PAVM : 1.7200 (+4.24%)

Barchart Exclusives

Nvidia vs. Tesla: Which Is the Better Buy for an Early 2026 Christmas Present? Barchart - 8 minutes ago
On Thursday, Nvidia and Tesla had an unusually active call option expiring in 939 days. I don’t think there’s any question about the smarter bet for an early Christmas present in 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot